Skye Bioscience, Inc. SKYE
0.84 USD +0.15 (+21.59%)
At closeNov 10, 2026, 7:58 PM EST
0.86 +0.02 +2.92%
After hours · Nov 10, 7:58 PM ET
0.7111 Day range 1.04
0.69 52-week range 12.16
- YTD
- -86.02%
- 1 year
- -92.61%
News
benzinga.com 12 Health Care Stocks Moving In Tuesday's After-Market Session Gainers Basel Medical Group (NASDAQ:BMGL) stock moved upwards by 13.9% to $2.2 during Tuesday's after-market session. The company's market cap stands at $73.3 million. Longeveron (NASDAQ:LGVN) stock…
prnewswire.com SPIN MASTER AND NICKELODEON ANNOUNCE NEW PAW PATROL® SPINOFF FEATURING SKYE Skye's Pup Squad™ debuts on Nickelodeon March 2027 Share it: @PAWPatrol @nickelodeon and @nickelodeonfamily TORONTO, Nov. 10, 2026 /PRNewswire/ -- Building on the success of PAW Patrol's films and…
benzinga.com 12 Health Care Stocks Moving In Tuesday's Pre-Market Session Gainers Co-Diagnostics (NASDAQ:CODX) stock moved upwards by 22.4% to $0.39 during Tuesday's pre-market session. The company's market cap stands at $2.8 million. As per the press release, Q3 earnings…
defenseworld.net 5Am Partners Vii, Llc Sells 33,892 Shares of Skye Bioscience (NASDAQ:SKYE) Stock Skye Bioscience, Inc. (NASDAQ: SKYE - Get Free Report) major shareholder 5Am Partners Vii, Llc sold 33,892 shares of Skye Bioscience stock in a transaction on Wednesday, September 16th. The shares…
defenseworld.net Andrew Schwab Sells 33,892 Shares of Skye Bioscience (NASDAQ:SKYE) Stock Skye Bioscience, Inc. (NASDAQ: SKYE - Get Free Report) Director Andrew Schwab sold 33,892 shares of Skye Bioscience stock in a transaction on Wednesday, September 16th. The stock was sold at an…- benzinga.com 12 Health Care Stocks Moving In Wednesday's Intraday Session Gainers Opus Genetics (NASDAQ:IRD) shares increased by 31.7% to $5.71 during Wednesday's regular session. The company's market cap stands at $361.0 million. bioAffinity Technologies (NASDAQ:BIAF)…
- benzinga.com 12 Health Care Stocks Moving In Monday's Pre-Market Session Gainers Redhill Biopharma (NASDAQ:RDHL) shares increased by 96.7% to $1.3 during Monday's pre-market session. The market value of their outstanding shares is at $4.0 million. Vivos Therapeutics…
benzinga.com Skye Bioscience (SKYE) Shares Rise 6% After Hours: Here's What's Driving The Move Skye Bioscience shares rise 6% after hours on a $22M equity purchase agreement and warrant issuance.
benzinga.com Skye Bioscience Enters Into Securities Purchase Agreement With Redmile Affiliate For Aggregate Purchase Price Of Up To $22M Entry into a Material Definitive Agreement. As previously disclosed on the Current Report on Form 8-K filed by Skye Bioscience, Inc., a Nevada corporation (the "Company"), with the U.S. Securities…
defenseworld.net Skye Bioscience to Merge With Redx, Forming Fibrosis-Focused Fibrx Therapeutics Skye Bioscience (NASDAQ: SKYE) and privately held Redx announced a definitive transaction agreement that would combine the companies into a Nasdaq-listed fibrosis-focused biotechnology company named…
benzinga.com Why HIVE Digital Technologies Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarket HIVE Digital Technologies Ltd (NASDAQ: HIVE) rose in pre-market trading due to its subsidiary's new agreement. Other gainers include IP Strategy Holdings, INVO Fertility, My Size, Trugolf Holdings,…
seekingalpha.com Skye Bioscience, Inc. (SKYE) M&A Call Prepared Remarks Transcript Skye Bioscience, Inc. (SKYE) M&A Call Prepared Remarks Transcript
benzinga.com Skye Bioscience To Acquire Redx Pharma; Combined Company To Operate As Fibrx Therapeutics With $125M Financing Combined company to trade on Nasdaq and operate as Fibrx Therapeutics, a fibrosis-focused company led by the Redx management team and board Company’s lead program will be RXC008, Redx’s GI-restricted…
globenewswire.com Skye Bioscience and Redx Pharma Announce Transaction Agreement and $125 Million in Financings Combined company to trade on Nasdaq and operate as Fibrx Therapeutics, a fibrosis-focused company led by the Redx management team and board Company's lead program will be RXC008, Redx's GI-restricted…- benzinga.com 12 Health Care Stocks Moving In Friday's Pre-Market Session Gainers Doximity (NYSE:DOCS) stock rose 85.1% to $38.25 during Friday's pre-market session. The market value of their outstanding shares is at $3.7 billion. As per the news, the Q1 earnings report…
defenseworld.net Skye Bioscience (NASDAQ:SKYE) Trading 2.8% Higher – Time to Buy? Skye Bioscience, Inc. (NASDAQ: SKYE - Get Free Report)'s share price was up 2.8% during mid-day trading on Monday. The stock traded as high as $0.5918 and last traded at $0.5842. Approximately…- benzinga.com Skye Bioscience To Switch Listing From Nasdaq Global Market To Nasdaq Capital Market, Effective June 23 On June 18, 2026, the Company received approval from the Staff to transfer the listing of the Company’s common stock, par value $0.001 per share (the "Common Stock"), from the Nasdaq Global Market to…
benzinga.com Skye Bioscience Says Cohort Review Committee Unanimously Approves Opening Second Cohort Of CBeyond Part C Expansion Study Skye Bioscience, Inc. (NASDAQ:SKYE), a clinical-stage biotechnology company focused on unlocking new therapeutic pathways for obesity and other metabolic health disorders, today announced that the…
globenewswire.com Skye Announces Cohort Review Committee Approved Opening of Cohort 2 Based on Favorable Safety Data from First Four Participants Treated in Cohort 1 SAN DIEGO, May 20, 2026 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (NASDAQ: SKYE), a clinical-stage biotechnology company focused on unlocking new therapeutic pathways for obesity and other metabolic…
globenewswire.com UPDATE – Skye Bioscience Reports First Quarter 2026 Financial Results and Business Update SAN DIEGO, May 12, 2026 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye” or the “Company”), a clinical stage biotechnology company developing next-generation molecules that modulate…
globenewswire.com Skye Bioscience Reports First Quarter 2026 Financial Results and Business Update SAN DIEGO, May 11, 2026 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye” or the “Company”), a clinical stage biotechnology company developing next-generation molecules that modulate…
benzinga.com 12 Health Care Stocks Moving In Monday's After-Market Session 
globenewswire.com Kuehn Law Encourages Investors of Skye Bioscience, Inc. to Contact Law Firm NEW YORK, April 22, 2026 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Skye Bioscience, Inc. (NASDAQ: SKYE)…
globenewswire.com Skye Bioscience Presenting at GLP-1-Based Therapeutics Summit SAN DIEGO, April 07, 2026 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”) a clinical-stage biotechnology company focused on unlocking new therapeutic pathways for obesity and other…
globenewswire.com Skye Bioscience Treats First Patient in Nimacimab Higher-Dose Expansion Study Evaluating Exposure-Response to Inform Phase 2b Dose Selection for GLP-1 Combination Development Topline safety and pharmacokinetic data expected in Q4 2026; an independent Data Monitoring Committee is overseeing the study Topline safety and pharmacokinetic data expected in Q4 2026; an…- benzinga.com 12 Health Care Stocks Moving In Monday's After-Market Session
- benzinga.com 12 Health Care Stocks Moving In Wednesday's Intraday Session
- benzinga.com 12 Health Care Stocks Moving In Wednesday's Pre-Market Session
benzinga.com Why Domo Shares Are Trading Higher By Around 49%; Here Are 20 Stocks Moving Premarket Domo Inc (DOMO) stock jumped 48.8% in pre-market trading after beating Q4 earnings expectations by 117.65% and reporting a rise in revenue.
seekingalpha.com Skye Bioscience, Inc. (SKYE) Q4 2025 Earnings Call Transcript Skye Bioscience, Inc. (SKYE) Q4 2025 Earnings Call Transcript
globenewswire.com Skye Bioscience Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update SAN DIEGO, March 10, 2026 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (NASDAQ: SKYE) (“Skye” or the “Company”), a clinical stage biopharmaceutical company pioneering next-generation molecules that…
benzinga.com Earnings Scheduled For March 10, 2026 
globenewswire.com Skye Bioscience to Announce 2025 Financial Results and Business Update on March 10, 2026 SAN DIEGO, March 05, 2026 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”), a clinical-stage biotechnology company focused on unlocking new therapeutic pathways for obesity and other…
benzinga.com 10 Health Care Stocks Moving In Monday's Pre-Market Session 
defenseworld.net Skye Bioscience, Inc. (NASDAQ:SKYE) Receives Average Recommendation of “Moderate Buy” from Analysts Shares of Skye Bioscience, Inc. (NASDAQ: SKYE - Get Free Report) have been given a consensus recommendation of "Moderate Buy" by the eight ratings firms that are presently covering the stock,…
benzinga.com Penny Stock Skye Bioscience Drug Combo With Wegovy Shows Over 22% Weight Loss After One Year Skye Bioscience, Inc. (NASDAQ: SKYE) on Monday shared interim 52-week data from the combination therapy arms in the extension phase of the Phase 2a CBeyond proof-of-concept study of nimacimab.
globenewswire.com Skye Reports Positive CBeyond Phase 2a Extension Interim Study Results for Nimacimab in Combination With Semaglutide 22.3% total weight loss at 52 weeks with nimacimab (200 mg dose) + semaglutide (2.4 mg) combination — no plateau observed, suggesting potential for further efficacy beyond one year and at higher…
globenewswire.com Skye Bioscience Highlights Attributes of its Peripherally-restricted CB1 Inhibitor Antibody at Keystone Obesity Conference SAN DIEGO, Jan. 29, 2026 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”) a clinical-stage biotechnology company focused on unlocking new therapeutic pathways for obesity and other…- benzinga.com 12 Health Care Stocks Moving In Tuesday's Intraday Session
- benzinga.com 12 Health Care Stocks Moving In Monday's Pre-Market Session
benzinga.com Why Multi Ways Holdings Shares Are Trading Higher By Around 60%; Here Are 20 Stocks Moving Premarket 
benzinga.com Earnings Scheduled For November 10, 2025 
benzinga.com Nasdaq Jumps Over 150 Points; Skye Bioscience Shares Plunge 
benzinga.com 12 Health Care Stocks Moving In Monday's Intraday Session 
benzinga.com US Stocks Mixed; Dow Falls 100 Points 
benzinga.com Why AMD Shares Are Trading Higher By Over 34%; Here Are 20 Stocks Moving Premarket - benzinga.com 12 Health Care Stocks Moving In Monday's Pre-Market Session
benzinga.com 12 Health Care Stocks Moving In Friday's After-Market Session Gainers Enanta Pharma (NASDAQ: ENTA) stock rose 15.6% to $9.13 during Friday's after-market session. The market value of their outstanding shares is at $165.6 million.
benzinga.com Earnings Scheduled For August 7, 2025 - benzinga.com 12 Health Care Stocks Moving In Monday's Intraday Session